QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
NASDAQ:SESN

Sesen Bio - SESN Stock Forecast, Price & News

$0.52
-0.01 (-1.89%)
(As of 12/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.51
$0.54
50-Day Range
$0.39
$0.57
52-Week Range
$0.37
$0.97
Volume
468,982 shs
Average Volume
2.67 million shs
Market Capitalization
$105.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SESN stock logo

About Sesen Bio (NASDAQ:SESN) Stock

Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscle invasive carcinoma in situ of the bladder in patients previously treated with BCG; and for the treatment of squamous cell carcinoma of the head and neck, as well as VB6-845d, a product candidate for use in the treatment of various types of an anti-epithelial cell adhesion molecule-positive solid tumors. Sesen Bio, Inc. has an agreement with Leiden University Medical Center to co-develop an imaging agent. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc. in May 2018. Sesen Bio, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

Receive SESN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sesen Bio and its competitors with MarketBeat's FREE daily newsletter.

SESN Stock News Headlines

Sesen Bio: Q3 Earnings Insights
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OCSL, SESN, ISR
The Petri Dish: Embattled Sesen Bio shuts down via merger
Sesen Bio Shares Sink After Merger News
Sesen Bio to Merge With Carisma Therapeutics
Sesen Bio, Carisma To Merge
Sesen Bio and Carisma Therapeutics Announce Merger Agreement
FDA Panel to Review Perrigo's (PRGO) OTC Birth Control Pill
Amylyx (AMLX) Up 51% After FDA Committee Endorses ALS Drug
GSK's NDA for Daprodustat to be Reviewed by an FDA Panel
See More Headlines
Receive SESN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sesen Bio and its competitors with MarketBeat's FREE daily newsletter.

SESN Company Calendar

Last Earnings
11/07/2022
Today
12/08/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/27/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SESN
Employees
35
Year Founded
N/A

Profitability

Net Income
$-340,000.00
Pretax Margin
-36.13%

Debt

Sales & Book Value

Annual Sales
$26.54 million
Cash Flow
$0.08 per share
Book Value
$0.86 per share

Miscellaneous

Free Float
196,269,000
Market Cap
$105.33 million
Optionable
Optionable
Beta
0.97

Key Executives

  • Dr. Thomas R. Cannell D.V.M. (Age 60)
    Pres, CEO & Director
    Comp: $798.61k
  • Ms. Monica Forbes (Age 46)
    CFO & Treasurer
    Comp: $527.4k
  • Dr. Glen C. MacDonald (Age 71)
    Chief Technology Officer
    Comp: $512.27k
  • Dr. Gregory L. Verdine Ph.D. (Age 63)
    Co-Founder
  • Ms. Elly Ryu (Age 41)
    Corp. Controller & Principal Accounting Officer
  • Ms. Erin Clark
    VP of Corp. Strategy & Investor Relations
  • Mr. Mark R. Sullivan (Age 51)
    Gen. Counsel & Corp. Sec.
  • Mr. John Knighton (Age 44)
    VP & Chief Compliance Officer
  • Mr. Steve Barbera
    VP of Market Access
  • Dr. David Brooks
    Sr. VP of Clinical Devel.













SESN Stock - Frequently Asked Questions

How have SESN shares performed in 2022?

Sesen Bio's stock was trading at $0.8150 at the beginning of 2022. Since then, SESN shares have decreased by 35.9% and is now trading at $0.5226.
View the best growth stocks for 2022 here
.

When is Sesen Bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 27th 2023.
View our SESN earnings forecast
.

How were Sesen Bio's earnings last quarter?

Sesen Bio, Inc. (NASDAQ:SESN) posted its quarterly earnings data on Monday, November, 7th. The company reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.22. The firm earned $0.04 million during the quarter.

What other stocks do shareholders of Sesen Bio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sesen Bio investors own include Amarin (AMRN), XOMA (XOMA), VBI Vaccines (VBIV), Advanced Micro Devices (AMD), Verastem (VSTM), Sorrento Therapeutics (SRNE), Novavax (NVAX), Biocept (BIOC), Micron Technology (MU) and OPKO Health (OPK).

What is Sesen Bio's stock symbol?

Sesen Bio trades on the NASDAQ under the ticker symbol "SESN."

Who are Sesen Bio's major shareholders?

Sesen Bio's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (5.35%), BlackRock Inc. (2.08%), Renaissance Technologies LLC (0.52%), Group One Trading L.P. (0.00%), Connor Clark & Lunn Investment Management Ltd. (0.07%) and Virtu Financial LLC (0.04%).

How do I buy shares of Sesen Bio?

Shares of SESN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sesen Bio's stock price today?

One share of SESN stock can currently be purchased for approximately $0.52.

How much money does Sesen Bio make?

Sesen Bio (NASDAQ:SESN) has a market capitalization of $105.96 million and generates $26.54 million in revenue each year. The company earns $-340,000.00 in net income (profit) each year or ($0.02) on an earnings per share basis.

How can I contact Sesen Bio?

Sesen Bio's mailing address is 245 FIRST STREET SUITE 1800, CAMBRIDGE MA, 02142. The official website for the company is www.sesenbio.com. The company can be reached via phone at (617) 444-8550, via email at ir@sesenbio.com, or via fax at 617-858-0911.

This page (NASDAQ:SESN) was last updated on 12/8/2022 by MarketBeat.com Staff